Share This:
https://ntp.niehs.nih.gov/go/alt-funding

Funding Opportunities for Test Method Developers

NICEATM and ICCVAM seek to facilitate development of test methods that replace, reduce, and refine the use of animals in testing and protect human health, animal health, and the environment. This page lists announcements of funding opportunities intended to support the development of alternative test methods. If you are aware of a funding opportunity that could be included on this page, please contact NICEATM.

SBIR and STTR Omnibus Grant Solicitations of the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration

As part of a large Department of Health and Human Services solicitation of Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications,  the National Institute of Environmental Health Sciences (NIEHS) is interested in technologies to improve predictivity in toxicology testing to support the goals and initiatives of Tox21. View more information on the NIEHS website.

SBIR/STTR Omnibus solicitations and accompanying resources:

Next due date: September 5, 2017

For more information about this opportunity contact:
Dr. Daniel T. Shaughnessy [Send email]
NIEHS Division of Extramural Research and Training
POB 12233 (K3-12), Research Triangle Park, NC 27709
(919) 541-2506, Fax: (919) 541-4606

Small Business Phase II Grants for Alternative Methods Development

NIEHS is funding grants to U.S. small businesses for development of medium- to high-throughput assays. Assays developed under these grants should evaluate the effects of toxicants on pluripotent or induced pluripotent cells with respect to cell differentiation and the resulting differentiated cell populations. The ability to incorporate genetic diversity in these assays would be useful. Results from these assays should help identify mechanisms of chemically induced biological activity, prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response.

Letters of intent for this funding opportunity are due September 4, with applications due October 4.

Full funding announcement on NIH website (posted June 23)

Information about applying for NIEHS small business grants

For more information about this opportunity contact:
Dr. Daniel T. Shaughnessy [Send email], NIEHS Division of Extramural Research and Training

Phase IIb SBIR Awards for Validation of Alternative Test Methods

NICEATM encourages U.S. small businesses involved in alternative methods development to apply for SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing offered by NIEHS. These awards are intended to support the validation of promising alternative test methods that replace or reduce animal use in toxicity testing/screening and can be used to address current U.S. federal agency testing requirements. Priority areas for alternative test method development and validation include (but are not limited to) ocular toxicity testing, reproductive and developmental toxicity testing, carcinogenicity testing, and acute toxicity testing. Funding is available through November 2017; the next due date for letters of intent is October 13, 2017.

Presentation summarizing the funding opportunity (September 2015) 

Complete description of the funding opportunity on the National Institutes of Health website
An update to the funding opportunity was issued on August 29, 2016

For more information about this opportunity contact:
Dr. Daniel T. Shaughnessy [Send email], NIEHS Division of Extramural Research and Training

NIH Funding Resources

The NIEHS SBIR/STTR Program Staff encourages applicants to submit grants at least one week before the deadline and to take advantage of the following resources:

Toxics Accepting Applications for Postdoc Travel Award

The journal Toxics is accepting applications for a travel award from postdoctoral fellows or trainees involved in toxicology research. The award of 800 Swiss francs (approximately $800 U.S.) will support travel to an international conference in 2018 at which the awardee will give an oral or poster presentation.

Applicants should submit the following to toxics@mdpi.com by November 30:

  • A 500-word description of current and future work
  • CV including complete publication list
  • A description of the conference to be attended and the work to be presented
  • A letter of recommendation from the applicant’s supervisor or PI

Applications will be assessed by an evaluation committee chaired by Toxics Editor-in-chief Prof. Dr. David Bellinger. The winner will be announced in January 2018.